Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Charalabos Vlachopoulos"'
Autor:
Evangelos Liberopoulos, George Ntaios, Emanouel Ganotakis, Christos Pitsavos, Apostolos Achimastos, Ioannis Lekakis, Panagiotis Vardas, Loukianos S. Rallidis, Dimitrios Vlahakos, Charalabos Vlachopoulos, Stavros Pappas, Moses Elisaf, Vasilios G. Athyros, Ioannis Ioannidis, Nicolaos Tentolouris, E. Bilianou, Dimitrios Tousoulis, Theodoras Alexandrides, Dimitrios J. Richter, Christina Chrysochoou, Vasilios Nikolaou, Nikolaos Papanas, Ioannis Skoumas, Genovefa Kolovou, Evridiki Drogari, Ioannis Goudevenos, Dimitrios Alexopoulos, Andreas Melidonis, Dimitrios Tziakas, Vasilios Kotsis, Konstantinos Tsioufis, A.D. Tselepis, Alexandra Bargiota, Konstantinos Tziomalos
Publikováno v:
Hormones. 15:8-14
Two proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, evolocumab and alirocumab, have recently been approved by both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for the treatment of hypercholesterole
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e98c044fcbccb87a62d53e29d537b221
https://doi.org/10.1007/bf03401398
https://doi.org/10.1007/bf03401398
